References
- Long Circulating Liposomes: Old Drugs, New Therapeutics, Landes Bioscience, M. C. Woodle, G. Storm. Springer-Verlag. 1998, (ISBN: 3–540–63082–1)
- Boerman O. C., Storm G., Oyen W. J. G., Van Bloois L., Van der Meer J. W. M., Claessens R. A. M. J., Crommelin D. J. A., Corstens F. H.M. Sterically stabilized liposomes labeled with indium-111 to image focal infection. J. Nucl. Med. 1995; 36: 1639–1644
- Boerman O. C., Oyen W. J. G., Van Bloois L., Koenders E. B., Van der Meer J. W. M., Corstens F. H. M., Storm G. Optimization of Tc-99m-labeled PEG-liposomes to image focal infection: effects of particle size and circulation time. J. Nucl. Med. 1997; 38: 489–493
- Boerman O. C., Oyen W. J. G., Storm G., Corvo L., Van Bloois L., Van der Meer J. W. M., Corstens F. H.M. Tc-99m labeled liposomes to image rheumatoid arthritis. Ann. Rheum. Dis. 1997; 56: 369–373
- Oyen W. J. G., Boerman O. C., Storm G., Van Bloois L., Koenders E. B., Crommelin D. J. A., Van der Meer J. W. M., Corstens F. H.M. Labeled Stealth liposomes in experimental infection: an alternative for leukocyte scintigraphy. Nucl. Med. Comm. 1996; 17: 742–748
- Dams E. T. M., Oyen W. J. G., Boerman O. C., Storm G., Laverman P., Koenders E. B., Van der Meer J. W. M., Corstens F. H.M. Technetium-99m-labeled liposomes to image experimental colitis in rabbits: Comparison with Technetium-99m-HMPAO-granulocytes and Technetium99m-HYNIC-IgG. J. Nucl. Med. 1998; 39: 2172–2178
- Dams E. T. M., Becker M. J., Oyen W. J. G., Boerman O. C., Storm G., Laverman P., De Marie S., Van der Meer J. W. M., Bakker-Woudenberg I. A. J. M., Corstens F. H.M. Scintigraphic imaging of bacterial and fungal infection in granulocytopenic rats. J. Nucl. Med. 2000; 40: 2066–2072
- Dams E. T. M., Reijnen M. M., Oyen W. J. G., Boerman O. C., Laverman P., Storm G., Van der Meer J. W. M., Corstens F. H. M., Van Goor H. Imaging experimental intraabdominal abscesses with 99mTc-PEG liposomes and 99mTc-HYNIC IgG. Ann. Surg. 1999; 229: 551–557
- Dams E. T. M., Nijhof M. W., Boerman O. C., Laverman P., Storm G., Buma P., Lemmens J. A. M., Van der Meer J. W. M., Corstens F. H. M., Oyen W. J.G. Scintigraphic evaluation of experimental chronic osteomyelitis. J. Nucl. Med. 2000; 41: 896–902
- Dams E. T. M., Oyen W. J. G., Boerman O. C., Storm G., Laverman P., Kok P. J. M., Koenders E. B., Buijs W. C. A. M., Van Bloois L., Bakker H., Van der Meer J. W. M., Corstens F. H.M. Tc-99m-PEG-liposomes for the scintigraphic detection of infection and inflammation: clinical evaluation. J. Nucl. Med. 2000; 41: 622–630
- Brouwers A. H., De Jong D. J., Dams E. T. M., Oyen W. J. G., Boerman O. C., Laverman P., Naber T. H. J., Storm G., Corstens F. H.M. Tc-99m-PEG-liposomes for the evaluation of colitis in Crohn's disease. J. Drug Targeting 2000, in press
- Laverman P., Brouwers A. H., Dams E. T. M., Oyen W. J. G., Storm G., Van Rooijen N., Corstens F. H. M., Boerman O. C. Preclinical and clinical evidence for disappearance of the long-circulating characteristics of PEG-liposomes at low lipid dose. J. Pharm. Exp. Ther. 2000; 293: 996–1001
- Goins B., Philips W. T., Klipper R. Repeat injection studies of technetium-99m-labeled PEG-liposomes in the same animal. J. Liposome Res. 1998; 8: 265–281
- Oussoren C., Storm G. Effect of repeated intravenous administration on the circulation kinetics of poly(ethyleneglycol)-liposomes in rats. J. Liposome Res. 1999; 9: 349–355
- Dams E. T. M., Laverman P., Oyen W. J. G., Storm G., Scherphof G. L., Van der Meer J. W. M., Corstens F. H. M., Boerman O. C. Accelerated blood clearance and altered biodistribution of repeated injections of sterically stabilized liposomes. J. Pharm. Exp. Ther. 2000; 292: 1071–1079
- Daemen T., Regts J., Meesters M., Ten Kate M. T., Bakker-Woudenberg I. A. J. M., Scherphof G. I. Toxicity of doxorubicin entrapped within long-circulating liposomes. J. Controlled Release 1997; 44: 1–9
- Storm G., Ten Kate M. T., Working P. K., Bakker-Woudenberg I. A. J. M. Doxorubicin entrapped in sterically stabilized liposomes: Effects on bacterial blood clearance capacity of the mononuclear phagocyte system. Clin. Cancer Res. 1998; 3: 111–115